Acetylation and insulin resistance: a focus on metabolic and mitogenic cascades of insulin signaling

References

• Lebovitz HE. Insulin resistance: definition and consequences. Exp Clin Endocrinol Diabetes. 2001;109:S135–S148.
   PubMed Web of Science ®Google Scholar
• Balcerczyk A, Chriett S, Pirola L. Insulin action, insulin resistance, and their link to histone acetylation. In: Patel VB, Preedy VR, editors. Handbook of nutrition, diet, and epigenetics. Cham: Springer International Publishing; 2017. p. 1–22.
   Google Scholar
• Choudhary C, Weinert BT, Nishida Y, et al. The growing landscape of lysine acetylation links metabolism and cell signalling. Nat Rev Mol Cell Biol. 2014;15:536.
   PubMed Web of Science ®Google Scholar
• Boucher J, Kleinridders A, Kahn CR. Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harb Perspect Biol. 2014;6:a009191.
   PubMed Web of Science ®Google Scholar
• Cohen P. The twentieth century struggle to decipher insulin signalling. Nat Rev Mol Cell Biol. 2006;7:867.
   PubMed Web of Science ®Google Scholar
• Taniguchi CM, Emanuelli B, Kahn CR. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol. 2006;7:85–96.
   PubMed Web of Science ®Google Scholar
• Taheripak G, Bakhtiyari S, Rajabibazl M, et al. Protein tyrosine phosphatase 1B inhibition ameliorates palmitate-induced mitochondrial dysfunction and apoptosis in skeletal muscle cells. Free Radic Biol Med. 2013;65:1435–1446.
   PubMed Web of Science ®Google Scholar
• Leto D, Saltiel AR. Regulation of glucose transport by insulin: traffic control of GLUT4. Nat Rev Mol Cell Biol. 2012;13:383–396.
   PubMed Web of Science ®Google Scholar
• Greer EL, Banko MR, Brunet A. AMP-activated protein kinase and FoxO transcription factors in dietary restriction-induced longevity. Ann NY Acad Sci. 2009;1170:688–692.
   PubMed Web of Science ®Google Scholar
• Ijuin T, Takenawa T. Regulation of insulin signaling and glucose transporter 4 (GLUT4) exocytosis by phosphatidylinositol 3,4,5-trisphosphate (PIP3) phosphatase, skeletal muscle, and kidney enriched inositol polyphosphate phosphatase (SKIP). J Biol Chem. 2012;287:6991–6999.
   PubMed Web of Science ®Google Scholar
• Towler MC, Hardie DG. AMP-activated protein kinase in metabolic control and insulin signaling. Circulation Res. 2007;100:328–341.
   PubMed Web of Science ®Google Scholar
• Lin J, Handschin C, Spiegelman BM. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab. 2005;1:361–370.
   PubMed Web of Science ®Google Scholar
• Finck BN, Kelly DP. PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J Clin Invest. 2006;116:615–622.
   PubMed Web of Science ®Google Scholar
• Khodabandehloo H, Gorgani-Firuzjaee S, Panahi G, et al. Molecular and cellular mechanisms linking inflammation to insulin resistance and beta-cell dysfunction. Transl Res. 2016;167:228–256.
   PubMed Web of Science ®Google Scholar
• Meshkani R, Adeli K. Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Clin Biochem. 2009;42:1331–1346.
   PubMed Web of Science ®Google Scholar
• Wilcox G. Insulin and insulin resistance. Clin Biochem Rev. 2005;26:19–39.
   PubMedGoogle Scholar
• Goldberg AD, Allis CD, Bernstein E. Epigenetics: a landscape takes shape. Cell. 2007;128:635–638.
   PubMed Web of Science ®Google Scholar
• Skinner MK, Manikkam M, Guerrero-Bosagna C. Epigenetic transgenerational actions of environmental factors in disease etiology. Trends Endocrinol Metab. 2010;21:214–222.
   PubMed Web of Science ®Google Scholar
• Kietrys AM, Kool ET. Epigenetics: a new methyl mark on messengers. Nature. 2016;530:423–424.
   PubMed Web of Science ®Google Scholar
• Bestor TH. The DNA methyltransferases of mammals. Hum Mol Genet. 2000;9:2395–2402.
   PubMed Web of Science ®Google Scholar
• Okano M, Bell DW, Haber DA, et al. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell. 1999;99:247–257.
   PubMed Web of Science ®Google Scholar
• Robertson KD. DNA methylation and human disease. Nat Rev Genet. 2005;6:597–610.
   PubMed Web of Science ®Google Scholar
• Shen Y, Chow J, Wang Z, et al. Abnormal CpG island methylation occurs during in vitro differentiation of human embryonic stem cells. Hum Mol Genet. 2006;15:2623–2635.
   PubMed Web of Science ®Google Scholar
• Gelato KA, Fischle W. Role of histone modifications in defining chromatin structure and function. Biol Chem. 2008;389:353–363.
   PubMed Web of Science ®Google Scholar
• Kuo MH, Allis CD. Roles of histone acetyltransferases and deacetylases in gene regulation. Bioessays. 1998;20:615–626.
   PubMed Web of Science ®Google Scholar
• De Ruijter AJ, Van Gennip AH, Caron HN, et al. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J. 2003;370:737–749.
   PubMed Web of Science ®Google Scholar
• Sauve AA, Wolberger C, Schramm VL, et al. The biochemistry of sirtuins. Annu Rev Biochem. 2006;75:435–465.
   PubMed Web of Science ®Google Scholar
• Kanwal R, Gupta S. Epigenetics and cancer. J Applied Physiol. 2010;109:598–605.
   PubMed Web of Science ®Google Scholar
• Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834–838.
   PubMed Web of Science ®Google Scholar
• Krützfeldt J, Stoffel M. MicroRNAs: a new class of regulatory genes affecting metabolism. Cell Metab. 2006;4:9–12.
   PubMed Web of Science ®Google Scholar
• Boehm M, Slack FJ. MicroRNA control of lifespan and metabolism. Cell Cycle. 2006;5:837–840.
   PubMed Web of Science ®Google Scholar
• Bandiera S, Hatem E, Lyonnet S, et al. microRNAs in diseases: from candidate to modifier genes. Clin Genet. 2010;77:306–313.
   PubMed Web of Science ®Google Scholar
• Mazloom H, Alizadeh S, Esfahani EN, et al. Decreased expression of microRNA-21 is associated with increased cytokine production in peripheral blood mononuclear cells (PBMCs) of obese type 2 diabetic and non-diabetic subjects. Mol Cell Biochem. 2016;419:11–17.
   PubMed Web of Science ®Google Scholar
• Mazloom H, Alizadeh S, Pasalar P, et al. Downregulated microRNA-155 expression in peripheral blood mononuclear cells of type 2 diabetic patients is not correlated with increased inflammatory cytokine production. Cytokine. 2015;76:403–408.
   PubMed Web of Science ®Google Scholar
• Alipoor B, Ghaedi H, Meshkani R, et al. The rs2910164 variant is associated with reduced miR-146a expression but not cytokine levels in patients with type 2 diabetes. J Endocrinol Invest. 2018;41:557–566.
   PubMed Web of Science ®Google Scholar
• Alipoor B, Ghaedi H, Meshkani R, et al. Association of MiR-146a expression and type 2 diabetes mellitus: a meta-analysis. Int J Mol Cell Med. 2017;6:156–163.
   PubMed Web of Science ®Google Scholar
• Pirola L, Zerzaihi O, Vidal H, et al. Protein acetylation mechanisms in the regulation of insulin and insulin-like growth factor 1 signalling. Mol Cell Endocrinol. 2012;362:1–10.
   PubMed Web of Science ®Google Scholar
• Choudhary C, Kumar C, Gnad F, et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science. 2009;325:834–840.
   PubMed Web of Science ®Google Scholar
• Sun C, Zhou J. Trichostatin A improves insulin stimulated glucose utilization and insulin signaling transduction through the repression of HDAC2. Biochem Pharmacol. 2008;76:120–127.
   PubMed Web of Science ®Google Scholar
• Lee YH, White MF. Insulin receptor substrate proteins and diabetes. Arch Pharm Res. 2004;27:361–370.
   PubMed Web of Science ®Google Scholar
• Kaiser C, James SR. Acetylation of insulin receptor substrate-1 is permissive for tyrosine phosphorylation. BMC Biol. 2004;2:23.
   PubMed Web of Science ®Google Scholar
• Gorgani-Firuzjaee S, Meshkani R. SH2 domain-containing inositol 5-phosphatase (SHIP2) inhibition ameliorates high glucose-induced de-novo lipogenesis and VLDL production through regulating AMPK/mTOR/SREBP1 pathway and ROS production in HepG2 cells. Free Radic Biol Med. 2015;89:679–689.
   PubMed Web of Science ®Google Scholar
• Sidiropoulos KG, Meshkani R, Avramoglu-Kohen R, et al. Insulin inhibition of apolipoprotein B mRNA translation is mediated via the PI-3 kinase/mTOR signaling cascade but does not involve internal ribosomal entry site (IRES) initiation. Arch Biochem Biophys. 2007;465:380–388.
   PubMed Web of Science ®Google Scholar
• Zhao S, Xu W, Jiang W, et al. Regulation of cellular metabolism by protein lysine acetylation. Science. 2010;327:1000–1004.
   PubMed Web of Science ®Google Scholar
• Cao J, Peng J, An H, et al. Endotoxemia-mediated activation of acetyltransferase P300 impairs insulin signaling in obesity. Nature Comm. 2017;8:131.
   PubMed Web of Science ®Google Scholar
• Stenbit AE, Tsao T-S, Li J, et al. GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes. Nat Med. 1997;3:1096–1101.
   PubMed Web of Science ®Google Scholar
• Bayley JS, Pedersen TH, Nielsen OB. Skeletal muscle dysfunction in the db/db mouse model of type 2 diabetes. Muscle Nerve. 2016;54:460–468.
   PubMed Web of Science ®Google Scholar
• Chriett S, Zerzaihi O, Vidal H, et al. The histone deacetylase inhibitor sodium butyrate improves insulin signalling in palmitate-induced insulin resistance in L6 rat muscle cells through epigenetically-mediated up-regulation of Irs1. Mol Cell Endocrinol. 2017;439:224–232.
   PubMed Web of Science ®Google Scholar
• Li Y, Xu W, McBurney MW, et al. SirT1 inhibition reduces IGF-I/IRS-2/Ras/ERK1/2 signaling and protects neurons. Cell Metab. 2008;8:38–48.
   PubMed Web of Science ®Google Scholar
• Zhang J. The direct involvement of SirT1 in insulin-induced insulin receptor substrate-2 tyrosine phosphorylation. J Biol Chem. 2007;282:34356–34364.
   PubMed Web of Science ®Google Scholar
• Sundaresan NR, Pillai VB, Wolfgeher D, et al. The deacetylase SIRT1 promotes membrane localization and activation of Akt and PDK1 during tumorigenesis and cardiac hypertrophy. Sci Signaling. 2011;4:ra46.
   PubMed Web of Science ®Google Scholar
• Hemmings BA, Restuccia DF. PI3K-PKB/Akt pathway. Cold Spring Harb Perspect Biol. 2012;4:a011189.
   PubMed Web of Science ®Google Scholar
• Chan C-H, Jo U, Kohrman A, et al. Posttranslational regulation of Akt in human cancer. Cell Biosci. 2014;4:59.
   PubMed Web of Science ®Google Scholar
• Ramakrishnan G, Davaakhuu G, Kaplun L, et al. Sirt2 deacetylase is a novel AKT binding partner critical for AKT activation by insulin. J Biol Chem. 2014;289:6054–6066.
   PubMed Web of Science ®Google Scholar
• Peng J, Li Q, Li K, et al. Quercetin improves glucose and lipid metabolism of diabetic rats: involvement of Akt signaling and SIRT1. J Diabetes Res. 2017;2017:3417306.
   PubMed Web of Science ®Google Scholar
• Alrob OA, Sankaralingam S, Ma C, et al. Obesity-induced lysine acetylation increases cardiac fatty acid oxidation and impairs insulin signalling. Cardiovasc Res. 2014;103:485–497.
   PubMed Web of Science ®Google Scholar
• Makarevic J, Tawanaie N, Juengel E, et al. Cross-communication between histone H3 and H4 acetylation and Akt-mTOR signalling in prostate cancer cells. J Cell Mol Med. 2014;18:1460–1466.
   PubMed Web of Science ®Google Scholar
• Ren J, Yang L, Zhu L, et al. Akt2 ablation prolongs life span and improves myocardial contractile function with adaptive cardiac remodeling: role of Sirt1‐mediated autophagy regulation. Aging Cell. 2017;16:976–987.
   PubMed Web of Science ®Google Scholar
• Banks AS, Kon N, Knight C, et al. SirT1 gain of function increases energy efficiency and prevents diabetes in mice. Cell Metab. 2008;8:333–341.
   PubMed Web of Science ®Google Scholar
• Arora A, Dey CS. SIRT2 negatively regulates insulin resistance in C2C12 skeletal muscle cells. Biochim Biophys Acta. 2014;1842:1372–1378.
   PubMed Web of Science ®Google Scholar
• Minokoshi Y, Kahn CR, Kahn BB. Tissue-specific ablation of the GLUT4 glucose transporter or the insulin receptor challenges assumptions about insulin action and glucose homeostasis. J Biol Chem. 2003;278:33609–33612.
   PubMed Web of Science ®Google Scholar
• Abel ED, Peroni O, Kim JK, et al. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature. 2001;409:729–733.
   PubMed Web of Science ®Google Scholar
• Neufer PD, Carey JO, Dohm GL. Transcriptional regulation of the gene for glucose transporter GLUT4 in skeletal muscle. Effects of diabetes and fasting. J Biol Chem. 1993;268:13824–13829.
   PubMed Web of Science ®Google Scholar
• Miska EA, Karlsson C, Langley E, et al. HDAC4 deacetylase associates with and represses the MEF2 transcription factor. Embo J. 1999;18:5099–5107.
   PubMed Web of Science ®Google Scholar
• Sparrow DB, Miska EA, Langley E, et al. MEF‐2 function is modified by a novel co‐repressor, MITR. Embo J. 1999;18:5085–5098.
   PubMed Web of Science ®Google Scholar
• Youn HD, Grozinger CM, Liu JO. Calcium regulates transcriptional repression of myocyte enhancer factor 2 by histone deacetylase 4. J Biol Chem y. 2000;275:22563–22567.
   PubMed Web of Science ®Google Scholar
• Thai MV, Guruswamy S, Cao KT, et al. Myocyte enhancer factor 2 (MEF2)-binding site is required for GLUT4 gene expression in transgenic mice. Regulation of MEF2 DNA binding activity in insulin-deficient diabetes. J Biol Chem y. 1998;273:14285–14292.
   PubMed Web of Science ®Google Scholar
• McGee SL, Hargreaves M. Exercise and myocyte enhancer factor 2 regulation in human skeletal muscle. Diabetes. 2004;53:1208–1214.
   PubMed Web of Science ®Google Scholar
• Ma K, Chan JK, Zhu G, et al. Myocyte enhancer factor 2 acetylation by p300 enhances its DNA binding activity, transcriptional activity, and myogenic differentiation. Mol Cell Biol. 2005;25:3575–3582.
   PubMed Web of Science ®Google Scholar
• Czubryt MP, McAnally J, Fishman GI, et al. Regulation of peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) and mitochondrial function by MEF2 and HDAC5. Proc Nat Acad Sci U S A. 2003;100:1711–1716.
   PubMed Web of Science ®Google Scholar
• Lu J, McKinsey TA, Nicol RL, et al. Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases. Proc Nat Acad Sci U S A. 2000;97:4070–4075.
   PubMed Web of Science ®Google Scholar
• McGee SL, van Denderen BJ, Howlett KF, et al. AMP-activated protein kinase regulates GLUT4 transcription by phosphorylating histone deacetylase 5. Diabetes. 2008;57:860–867.
   PubMed Web of Science ®Google Scholar
• Suter MA, Ma J, Vuguin PM, et al. In utero exposure to a maternal high-fat diet alters the epigenetic histone code in a murine model. Am J Obstet Gynecol. 2014;210:463.e1–463.e11.
   PubMedGoogle Scholar
• Zheng S, Rollet M, Pan YX. Protein restriction during gestation alters histone modifications at the glucose transporter 4 (GLUT4) promoter region and induces GLUT4 expression in skeletal muscle of female rat offspring. J Nutr Biochem. 2012;23:1064–1071.
   PubMed Web of Science ®Google Scholar
• Ciccarelli M, Vastolo V, Albano L, et al. Glucose-induced expression of the homeotic transcription factor Prep1 is associated with histone post-translational modifications in skeletal muscle. Diabetologia. 2016;59:176–186.
   PubMed Web of Science ®Google Scholar
• Renguet E, Ginion A, Gelinas R, et al. Metabolism and acetylation contribute to leucine-mediated inhibition of cardiac glucose uptake. Am J Physiol Heart Circul Physiol. 2017;313:H432–H445.
   PubMed Web of Science ®Google Scholar
• Fernandez-Marcos PJ, Auwerx J. Regulation of PGC-1alpha, a nodal regulator of mitochondrial biogenesis. Am J Clin Nutr. 2011;93:884S–8890.
   PubMed Web of Science ®Google Scholar
• Liang H, Ward WF. PGC-1alpha: a key regulator of energy metabolism. Adv Physiol Educ. 2006;30:145–151.
   PubMed Web of Science ®Google Scholar
• Jones AWE, Yao Z, Vicencio JM, et al. PGC-1 family coactivators and cell fate: roles in cancer, neurodegeneration, cardiovascular disease and retrograde mitochondria–nucleus signalling. Mitochondrion. 2012;12:86–99.
   PubMed Web of Science ®Google Scholar
• Jeninga EH, Schoonjans K, Auwerx J. Reversible acetylation of PGC-1: connecting energy sensors and effectors to guarantee metabolic flexibility. Oncogene. 2010;29:4617–4624.
   PubMed Web of Science ®Google Scholar
• Rodgers JT, Lerin C, Haas W, et al. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature. 2005;434:113–118.
   PubMed Web of Science ®Google Scholar
• Rodgers JT, Puigserver P. Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1. P Proc National Acad Sci USA. 2007;104:12861–12866.
   PubMed Web of Science ®Google Scholar
• Gerhart-Hines Z, Rodgers JT, Bare O, et al. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. Embo J. 2007;26:1913–1923.
   PubMed Web of Science ®Google Scholar
• Kelly TJ, Lerin C, Haas W, et al. GCN5-mediated transcriptional control of the metabolic coactivator PGC-1beta through lysine acetylation. J Biol Chem. 2009;284:19945–19952.
   PubMed Web of Science ®Google Scholar
• Lagouge M, Argmann C, Gerhart-Hines Z, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell. 2006;127:1109–1122.
   PubMed Web of Science ®Google Scholar
• Iwabu M, Yamauchi T, Okada-Iwabu M, et al. Adiponectin and adipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1. Nature. 2010;464:1313–1319.
   PubMed Web of Science ®Google Scholar
• Sharabi K, Lin H, Tavares CD, et al. Selective chemical inhibition of PGC-1alpha gluconeogenic activity ameliorates type 2 diabetes. Cell. 2017;169:148–160.
   PubMed Web of Science ®Google Scholar
• Krishnan J, Danzer C, Simka T, et al. Dietary obesity-associated Hif1alpha activation in adipocytes restricts fatty acid oxidation and energy expenditure via suppression of the Sirt2-NAD + system. Genes Dev. 2012;26:259–270.
   PubMed Web of Science ®Google Scholar
• Sun C, Wang M, Liu X, et al. PCAF improves glucose homeostasis by suppressing the gluconeogenic activity of PGC-1alpha. Cell Rep. 2014;9:2250–2262.
   PubMed Web of Science ®Google Scholar
• Zhang SY, Xu MJ, Wang X. Adrenomedullin 2/intermedin: a putative drug candidate for treatment of cardiometabolic diseases. Br J Pharmacol. 2018;175:1230–1240.
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhang SY, Jiang C, et al. Intermedin/adrenomedullin 2 polypeptide promotes adipose tissue browning and reduces high-fat diet-induced obesity and insulin resistance in mice. Int J Obes. 2016;40:852–860.
   Web of Science ®Google Scholar
• Kintscher U, Law RE. PPARgamma-mediated insulin sensitization: the importance of fat versus muscle. Am J Physiol Endocrinol Metab. 2005;288:E287–91.
   PubMed Web of Science ®Google Scholar
• Grygiel-Gorniak B. Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications–a review. Nutr J. 2014;13:17.
   PubMed Web of Science ®Google Scholar
• Jiang X, Ye X, Guo W, et al. Inhibition of HDAC3 promotes ligand-independent PPARgamma activation by protein acetylation. J Mol Endocrinol. 2014;53:191–200.
   PubMed Web of Science ®Google Scholar
• Mayoral R, Osborn O, McNelis J, et al. Adipocyte SIRT1 knockout promotes PPARgamma activity, adipogenesis and insulin sensitivity in chronic-HFD and obesity. Mol Metab. 2015;4:378–391.
   PubMed Web of Science ®Google Scholar
• Zhang X, Tang N, Hadden TJ, et al. Akt, FoxO and regulation of apoptosis. Biochim Biophys Acta. 2011;1813:1978–1986.
   PubMed Web of Science ®Google Scholar
• Kim MY, Bae JS, Kim TH, et al. Role of transcription factor modifications in the pathogenesis of insulin resistance. Exp Diabetes Res. 2012;2012:716425.
   PubMedGoogle Scholar
• Kuang J, Zhang Y, Liu Q, et al. Fat-specific Sirt6 ablation sensitizes mice to high-fat diet-induced obesity and insulin resistance by inhibiting lipolysis. Diabetes. 2017;66:1159–1171.
   PubMed Web of Science ®Google Scholar
• Sengupta A, Molkentin JD, Yutzey KE. FoxO transcription factors promote autophagy in cardiomyocytes. J Biol Chem. 2009;284:28319–28331.
   PubMed Web of Science ®Google Scholar
• Coll AP, Farooqi IS, Challis BG, et al. Proopiomelanocortin and energy balance: insights from human and murine genetics. J Clin Endocrinol Metab. 2004;89:2557–2562.
   PubMed Web of Science ®Google Scholar
• Susanti VY, Sasaki T, Yokota-Hashimoto H, et al. Sirt1 rescues the obesity induced by insulin-resistant constitutively-nuclear FoxO1 in POMC neurons of male mice. Obesity (Silver Spring). 2014;22:2115–2119.
   PubMed Web of Science ®Google Scholar
• Sin TK, Yu AP, Yung BY, et al. Modulating effect of SIRT1 activation induced by resveratrol on Foxo1-associated apoptotic signalling in senescent heart. J Physiol. 2014;592:2535–2548.
   PubMed Web of Science ®Google Scholar
• Banks AS, Kim-Muller JY, Mastracci TL, et al. Dissociation of the glucose and lipid regulatory functions of FoxO1 by targeted knockin of acetylation-defective alleles in mice. Cell Metab. 2011;14:587–597.
   PubMed Web of Science ®Google Scholar
• Cheng Z, Guo S, Copps K, et al. Foxo1 integrates insulin signaling with mitochondrial function in the liver. Nat Med. 2009;15:1307–1311.
   PubMed Web of Science ®Google Scholar
• Li H, Xu M, Lee J, et al. Leucine supplementation increases SIRT1 expression and prevents mitochondrial dysfunction and metabolic disorders in high-fat diet-induced obese mice. Am J Physiol Endocrinol Metab. 2012;303:E1234–44.
   PubMed Web of Science ®Google Scholar
• Feige JN, Lagouge M, Canto C, et al. Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. Cell Metab. 2008;8:347–358.
   PubMed Web of Science ®Google Scholar
• Du K, Herzig S, Kulkarni RN, et al. TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science. 2003;300:1574–1577.
   PubMed Web of Science ®Google Scholar
• Lundby A, Lage K, Weinert BT, et al. Proteomic analysis of lysine acetylation sites in rat tissues reveals organ specificity and subcellular patterns. Cell Rep. 2012;2:419–431.
   PubMed Web of Science ®Google Scholar
• Wang Q, Zhang Y, Yang C, et al. Acetylation of metabolic enzymes coordinates carbon source utilization and metabolic flux. Science. 2010;327:1004–1007.
   PubMed Web of Science ®Google Scholar
• Zhang T, Wang S, Lin Y, et al. Acetylation negatively regulates glycogen phosphorylase by recruiting protein phosphatase 1. Cell Metab. 2012;15:75–87.
   PubMed Web of Science ®Google Scholar
• Monteserin-Garcia J, Al-Massadi O, Seoane LM, et al. Sirt1 inhibits the transcription factor CREB to regulate pituitary growth hormone synthesis. Faseb J. 2013;27:1561–1571.
   PubMed Web of Science ®Google Scholar
• Bond ST, Howlett KF, Kowalski GM, et al. Lysine post-translational modification of glyceraldehyde-3-phosphate dehydrogenase regulates hepatic and systemic metabolism. Faseb J. 2017;31:2592–2602.
   PubMed Web of Science ®Google Scholar
• Mori J, Alrob OA, Wagg CS, et al. ANG II causes insulin resistance and induces cardiac metabolic switch and inefficiency: a critical role of PDK4. Am J Physiol Heart Circul Physiol. 2013;304:H1103–13.
   PubMed Web of Science ®Google Scholar
• Lantier L, Williams AS, Williams IM, et al. SIRT3 is crucial for maintaining skeletal muscle insulin action and protects against severe insulin resistance in high-fat-fed mice. Diabetes. 2015;64:3081–3092.
   PubMed Web of Science ®Google Scholar
• Ravnskjaer K, Hogan MF, Lackey D, et al. Glucagon regulates gluconeogenesis through KAT2B- and WDR5-mediated epigenetic effects. J Clin Invest. 2013;123:4318–4328.
   PubMed Web of Science ®Google Scholar
• Jia Y, Cong R, Li R, et al. Maternal low-protein diet induces gender-dependent changes in epigenetic regulation of the glucose-6-phosphatase gene in newborn piglet liver. J Nutr. 2012;142:1659–1665.
   PubMed Web of Science ®Google Scholar
• Honma K, Kamikubo M, Mochizuki K, et al. Insulin-induced inhibition of gluconeogenesis genes, including glutamic pyruvic transaminase 2, is associated with reduced histone acetylation in a human liver cell line. Metabolism. 2017;71:118–124.
   PubMed Web of Science ®Google Scholar
• Hardie DG, Ross FA, Hawley SA. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol. 2012;13:251–262.
   PubMed Web of Science ®Google Scholar
• Herzig S, Shaw RJ. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol. 2018;19:121–135.
   PubMed Web of Science ®Google Scholar
• Ruderman NB, Xu XJ, Nelson L, et al. AMPK and SIRT1: a long-standing partnership?. Am J Physiol Endocrinol Metab. 2010;298:E751–60.
   PubMed Web of Science ®Google Scholar
• Silvestre MF, Viollet B, Caton PW, et al. The AMPK-SIRT signaling network regulates glucose tolerance under calorie restriction conditions. Life Sci. 2014;100:55–60.
   PubMed Web of Science ®Google Scholar
• Arab Sadeghabadi Z, Nourbakhsh M, Pasalar P, et al. Reduced gene expression of sirtuins and active AMPK levels in children and adolescents with obesity and insulin resistance. Obes Res Clin Pract. 2018;12:167–173.
   PubMed Web of Science ®Google Scholar
• Tao X, Chen L, Cai L, et al. Regulatory effects of the AMPKalpha-SIRT1 molecular pathway on insulin resistance in PCOS mice: an in vitro and in vivo study. Biochem Biophys Res Comm. 2017;494:615–620.
   PubMed Web of Science ®Google Scholar
• Rogacka D, Piwkowska A, Audzeyenka I, et al. SIRT1-AMPK crosstalk is involved in high glucose-dependent impairment of insulin responsiveness in primary rat podocytes. Exp Cell Res. 2016;349:328–338.
   PubMed Web of Science ®Google Scholar
• Canto C, Gerhart-Hines Z, Feige JN, et al. AMPK regulates energy expenditure by modulating NAD + metabolism and SIRT1 activity. Nature. 2009;458:1056–1060.
   PubMed Web of Science ®Google Scholar
• Zheng Z, Chen H, Li J, et al. Sirtuin 1-mediated cellular metabolic memory of high glucose via the LKB1/AMPK/ROS pathway and therapeutic effects of metformin. Diabetes. 2012;61:217–228.
   PubMed Web of Science ®Google Scholar
• Rogacka D, Audzeyenka I, Rychłowski M, et al. Metformin overcomes high glucose-induced insulin resistance of podocytes by pleiotropic effects on SIRT1 and AMPK. Biochim Biophys Acta. 2018;1864:115–125.
   Web of Science ®Google Scholar
• Banerjee J, Bruckbauer A, Zemel MB. Activation of the AMPK/Sirt1 pathway by a leucine-metformin combination increases insulin sensitivity in skeletal muscle, and stimulates glucose and lipid metabolism and increases life span in Caenorhabditis elegans. Metabolism. 2016;65:1679–1691.
   PubMed Web of Science ®Google Scholar
• Canto C, Jiang LQ, Deshmukh AS, et al. Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab. 2010;11:213–219.
   PubMed Web of Science ®Google Scholar
• Liu Z, Jiang C, Zhang J, et al. Resveratrol inhibits inflammation and ameliorates insulin resistant endothelial dysfunction via regulation of AMP-activated protein kinase and sirtuin 1 activities. J Diabetes. 2016;8:324–335.
   PubMed Web of Science ®Google Scholar
• McGee SL, Hargreaves M. AMPK-mediated regulation of transcription in skeletal muscle. Clin Science (Lond). 2010;118:507–518.
   PubMed Web of Science ®Google Scholar
• Vilchinskaya NA, Krivoi II, Shenkman BS. AMP-activated protein kinase as a key trigger for the disuse-induced skeletal muscle remodeling. Int J Mol Sci. 2018;19:3558.
   Web of Science ®Google Scholar
• Huang J, Simcox J, Mitchell TC, et al. Iron regulates glucose homeostasis in liver and muscle via AMP-activated protein kinase in mice. Faseb J. 2013;27:2845–2854.
   PubMed Web of Science ®Google Scholar
• Gehart H, Kumpf S, Ittner A, et al. MAPK signalling in cellular metabolism: stress or wellness? EMBO Rep. 2010;11:834–840.
   PubMed Web of Science ®Google Scholar
• Whitmarsh AJ. Regulation of gene transcription by mitogen-activated protein kinase signaling pathways. Bioch Biophys Acta Mol Cell Res. 2007;1773:1285–1298.
   PubMed Web of Science ®Google Scholar
• Fröjdö S, Vidal H, Pirola L. Alterations of insulin signaling in type 2 diabetes: a review of the current evidence from humans. Bioch Biophys Acta. 2009;1792:83–92.
   PubMed Web of Science ®Google Scholar
• Lawrence M, Shao C, Duan L, et al. The protein kinases ERK1/2 and their roles in pancreatic beta cells. Acta Physiol (Oxford). 2007;192:11–17.
   Web of Science ®Google Scholar
• Ozaki KI, Awazu M, Tamiya M, et al. Targeting the ERK signaling pathway as a potential treatment for insulin resistance and type 2 diabetes. Am J Physiol Endocrinol Metab. 2016;310:E643–e651.
   PubMed Web of Science ®Google Scholar
• Xu Z, Tong Q, Zhang Z, et al. Inhibition of HDAC3 prevents diabetic cardiomyopathy in OVE26 mice via epigenetic regulation of DUSP5-ERK1/2 pathway. Clinical Sci (Lond). 2017;131:1841–1857.
   PubMed Web of Science ®Google Scholar
• Ferguson BS, Harrison BC, Jeong MY, et al. Signal-dependent repression of DUSP5 by class I HDACs controls nuclear ERK activity and cardiomyocyte hypertrophy. Proc National Acad Sci U S A. 2013;110:9806–9811.
   PubMed Web of Science ®Google Scholar
• Khan S, Jena GB. Protective role of sodium butyrate, a HDAC inhibitor on beta-cell proliferation, function and glucose homeostasis through modulation of p38/ERK MAPK and apoptotic pathways: study in juvenile diabetic rat. Chem Biol Interact. 2014;213:1–12.
   PubMed Web of Science ®Google Scholar
• Fischer A, Muhlhauser WWD, Warscheid B, et al. Membrane localization of acetylated CNK1 mediates a positive feedback on RAF/ERK signaling. Sci Adv. 2017;3:e1700475.
   PubMed Web of Science ®Google Scholar
• Solinas G, Becattini B. JNK at the crossroad of obesity, insulin resistance, and cell stress response. Mol Metab. 2017;6:174–184.
   PubMed Web of Science ®Google Scholar
• de Kreutzenberg SV, Ceolotto G, Papparella I, et al. Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms. Diabetes. 2010;59:1006–1015.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang Y, Luo M, et al. Novel curcumin analog C66 prevents diabetic nephropathy via JNK pathway with the involvement of p300/CBP-mediated histone acetylation. Biochim Biophys Acta. 2015;1852:34–46.
   PubMed Web of Science ®Google Scholar
• Cuadrado A, Nebreda AR. Mechanisms and functions of p38 MAPK signalling. Biochem J. 2010;429:403–417.
   PubMed Web of Science ®Google Scholar
• Pillai VB, Sundaresan NR, Samant SA, et al. Acetylation of a conserved lysine residue in the ATP binding pocket of p38 augments its kinase activity during hypertrophy of cardiomyocytes. Mol Cell Biol. 2011;31:2349–2363.
   PubMed Web of Science ®Google Scholar
• Xu T, Liu Y, Deng Y, et al. [Insulin combined with selenium inhibit p38MAPK/CBP pathway and suppresses cardiomyocyte apoptosis in rats with diabetic cardiomyopathy]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016;32:926–930.
   PubMedGoogle Scholar
• Kim SJ, Nian C, McIntosh CH. Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 modulate beta-cell chromatin structure. J Biol Chem. 2009;284:12896–12904.
   PubMed Web of Science ®Google Scholar
• Williams CB, Hughes MC, Edgett BA, et al. An examination of resveratrol’s mechanisms of action in human tissue: impact of a single dose in vivo and dose responses in skeletal muscle ex vivo. PloS One. 2014;9:e102406.
   PubMed Web of Science ®Google Scholar
• Kwak SH, Park KS. Recent progress in genetic and epigenetic research on type 2 diabetes. Exp Mol Med. 2016;48:e220.
   PubMed Web of Science ®Google Scholar
• Ling C, Groop L. Epigenetics: a molecular link between environmental factors and type 2 diabetes. Diabetes. 2009;58:2718–2725.
   PubMed Web of Science ®Google Scholar
• Ban N, Yamada Y, Someya Y, et al. Hepatocyte nuclear factor-1alpha recruits the transcriptional co-activator p300 on the GLUT2 gene promoter. Diabetes. 2002;51:1409–1418.
   PubMed Web of Science ®Google Scholar
• Párrizas M, Maestro MA, Boj SF, et al. Hepatic nuclear factor 1-alpha directs nucleosomal hyperacetylation to its tissue-specific transcriptional targets. Mol Cell Biol. 2001;21:3234–3243.
   PubMed Web of Science ®Google Scholar
• Kim KA, Kang K, Chi YI, et al. Identification and functional characterization of a novel mutation of hepatocyte nuclear factor-1alpha gene in a Korean family with MODY3. Diabetologia. 2003;46:721–727.
   PubMed Web of Science ®Google Scholar
• Mosley AL, Ozcan S. Glucose regulates insulin gene transcription by hyperacetylation of histone h4. J Biol Chem. 2003;278:19660–19666.
   PubMed Web of Science ®Google Scholar
• Qiu Y, Guo M, Huang S, et al. Insulin gene transcription is mediated by interactions between the p300 coactivator and PDX-1, BETA2, and E47. Mol Cell Biol. 2002;22:412–420.
   PubMed Web of Science ®Google Scholar
• Stanojevic V, Habener JF, Thomas MK. Pancreas duodenum homeobox-1 transcriptional activation requires interactions with p300. Endocrinology. 2004;145:2918–2928.
   PubMed Web of Science ®Google Scholar
• Mosley AL, Ozcan S. The pancreatic duodenal homeobox-1 protein (Pdx-1) interacts with histone deacetylases Hdac-1 and Hdac-2 on low levels of glucose. J Biol Chem. 2004;279:54241–54247.
   PubMed Web of Science ®Google Scholar
• Malecki MT, Jhala US, Antonellis A, et al. Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. Nat Genet. 1999;23:323–328.
   PubMed Web of Science ®Google Scholar
• Zeng Z, Liao R, Yao Z, et al. Three single nucleotide variants of the HDAC gene are associated with type 2 diabetes mellitus in a Chinese population: a community-based case-control study. Gene. 2014;533:427–433.
   PubMed Web of Science ®Google Scholar
• Rai E, Sharma S, Kaul S, et al. The interactive effect of SIRT1 promoter region polymorphism on type 2 diabetes susceptibility in the North Indian population. PloS One. 2012;7:e48621.
   PubMed Web of Science ®Google Scholar
• Rosen ED, Kaestner KH, Natarajan R, et al. Epigenetics and Epigenomics: implications for Diabetes and Obesity. Diabetes. 2018;67:1923–1931.
   PubMed Web of Science ®Google Scholar
• McGee SL, Hargreaves M. Exercise and skeletal muscle glucose transporter 4 expression: molecular mechanisms. Clin Exp Pharmacol Physiol. 2006;33:395–399.
   PubMed Web of Science ®Google Scholar
• Vissing K, McGee SL, Roepstorff C, et al. Effect of sex differences on human MEF2 regulation during endurance exercise. Am J Physiol Endocrinol Metab. 2008;294:E408–15.
   PubMed Web of Science ®Google Scholar
• Hanover JA. Epigenetics gets aweeter: O-GlcNAc joins the “histone code”. Chem Biol. 2010;17:1272–1274.
   PubMedGoogle Scholar
• Yang X, Qian K. Protein O-GlcNAcylation: emerging mechanisms and functions. Nat Rev Mol Cell Biol. 2017;18:452–465.
   PubMed Web of Science ®Google Scholar
• Ma J, Hart GW. Protein O-GlcNAcylation in diabetes and diabetic complications. Expert Rev Proteomics. 2013;10:365–380.
   PubMed Web of Science ®Google Scholar
• Lubas WA, Hanover JA. Functional expression of O-linked GlcNAc transferase. Domain structure and substrate specificity. J Biol Chem. 2000;275:10983–10988.
   PubMed Web of Science ®Google Scholar
• Housley MP, Rodgers JT, Udeshi ND, et al. O-GlcNAc regulates FoxO activation in response to glucose. J Biol Chem. 2008;283:16283–16292.
   PubMed Web of Science ®Google Scholar
• Whelan SA, Dias WB, Thiruneelakantapillai L, et al. Regulation of insulin receptor substrate 1 (IRS-1)/AKT kinase-mediated insulin signaling by O-Linked beta-N-acetylglucosamine in 3T3-L1 adipocytes. J Biol Chem. 2010;285:5204–5211.
   PubMed Web of Science ®Google Scholar
• Wang Z, Pandey A, Hart GW. Dynamic interplay between O-linked N-acetylglucosaminylation and glycogen synthase kinase-3-dependent phosphorylation. Mol Cell Proteomics. 2007;6:1365–1379.
   PubMed Web of Science ®Google Scholar
• Hardivillé S, Hart GW. Nutrient regulation of signaling, transcription, and cell physiology by O-GlcNAcylation. Cell Metab. 2014;20:208–213.
   PubMed Web of Science ®Google Scholar
• Kaasik K, Kivimae S, Allen JJ, et al. Glucose sensor O-GlcNAcylation coordinates with phosphorylation to regulate circadian clock. Cell Metab. 2013;17:291–302.
   PubMed Web of Science ®Google Scholar
• Sola-Penna M, Da Silva D, Coelho WS, et al. Regulation of mammalian muscle type 6-phosphofructo-1-kinase and its implication for the control of the metabolism. IUBMB Life. 2010;62:791–796. Nov
   PubMed Web of Science ®Google Scholar
• Yi W, Clark PM, Mason DE, et al. Phosphofructokinase 1 glycosylation regulates cell growth and metabolism. Science. 2012;337:975–980.
   PubMed Web of Science ®Google Scholar
• Haxho F, Haq S, Szewczuk MR. Biased G protein-coupled receptor agonism mediates Neu1 sialidase and matrix metalloproteinase-9 crosstalk to induce transactivation of insulin receptor signaling. Cell Signal. 2018;43:71–84.
   PubMed Web of Science ®Google Scholar
• Riddy DM, Delerive P, Summers RJ, et al. G protein–coupled receptors targeting insulin resistance, obesity, and type 2 diabetes mellitus. Pharmacol Rev. 2018;70:39–67.
   PubMed Web of Science ®Google Scholar
• Rozengurt E, Sinnett-Smith J, Kisfalvi K. Crosstalk between insulin/insulin-like growth factor-1 receptors and G protein-coupled receptor signaling systems: a novel target for the antidiabetic drug metformin in pancreatic cancer. Clin Cancer Res. 2010;16:2505–2511.
   PubMed Web of Science ®Google Scholar
• Spiegelberg BD. G protein coupled-receptor signaling and reversible lysine acetylation. J Recept Signal Transduct Res. 2013;33:261–266.
   PubMed Web of Science ®Google Scholar
• Alfonzo-Méndez MA, Alcántara-Hernández R, García-Sáinz JA. Novel structural approaches to study GPCR regulation. Int J Mol Sci. 2016;18:27.
   Web of Science ®Google Scholar